Association of HLA‐ DRB1 *09:01 with severe COVID ‐19-Reference-Cited by-同舟云学术

Association of HLA‐ DRB1 *09:01 with severe COVID ‐19

Published:2021-04-13 Issue:1 Volume:98 Page:37-42
ISSN:2059-2302
Container-title:HLA
language:en
Short-container-title:HLA

Author:

Anzurez Alitzel¹²,Naka Izumi³,Miki Shoji¹,Nakayama‐Hosoya Kaori¹,Isshiki Mariko³,Watanabe Yusuke³,Nakamura‐Hoshi Midori¹,Seki Sayuri¹,Matsumura Takayuki⁴,Takano Tomohiro⁴,Onodera Taishi⁴,Adachi Yu⁴,Moriyama Saya⁴,Terahara Kazutaka⁴,Tachikawa Natsuo⁵,Yoshimura Yoshihiro⁵,Sasaki Hiroaki⁵,Horiuchi Hiroshi⁵,Miyata Nobuyuki⁵,Miyazaki Kazuhito⁵,Koga Michiko⁶,Ikeuchi Kazuhiko⁶,Nagai Hiroyuki⁶,Saito Makoto⁶,Adachi Eisuke⁶,Yotsuyanagi Hiroshi⁶,Kutsuna Satoshi⁷,Kawashima Akira⁷,Miyazato Yusuke⁷,Kinoshita Noriko⁷,Kouno Chiyoko⁸,Tanaka Kensuke⁸,Takahashi Yoshimasa⁴,Suzuki Tadaki⁹,Matano Tetsuro¹²¹⁰,Ohashi Jun³,Kawana‐Tachikawa Ai¹²¹⁰^ORCID

Affiliation:

1. AIDS Research Center National Institute of Infectious Diseases Tokyo Japan

2. Joint Research Center for Human Retrovirus Infection Kumamoto University Kumamoto Japan

3. Department of Biological Sciences Graduate School of Science, University of Tokyo Tokyo Japan

4. Department of Immunology National Institute of Infectious Diseases Tokyo Japan

5. Department of Infectious Diseases Yokohama Municipal Citizens' Hospital Kanagawa Japan

6. Division of Infectious Diseases, Advanced Clinical Research Center Institute of Medical Science, University of Tokyo Tokyo Japan

7. Disease Control and Prevention Center National Center for Global Health and Medicine Tokyo Japan

8. JR Tokyo General Hospital Tokyo Japan

9. Department of Pathology National Institute of Infectious Diseases Tokyo Japan

10. Department of AIDS Vaccine Development Institute of Medical Science, University of Tokyo Tokyo Japan

Funder

Ministry of Education, Culture, Sports, Science and Technology

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Genetics,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tan.14256

Reference15 articles.

1. Coronavirus Disease 2019 Case Surveillance — United States, January 22–May 30, 2020

2. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

3. Estimating the burden of SARS-CoV-2 in France

4. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA

5. Significant Association of KIR2DL3-HLA-C1 Combination with Cerebral Malaria and Implications for Co-evolution of KIR and HLA

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential epitope prediction across diverse circulating variants of SARS-COV-2 in Brazil;Computational Biology and Chemistry;2024-10

2. Killer‐cell immunoglobulin‐like receptor polymorphism is associated with COVID‐19 outcome: Results of a pilot observational study;HLA;2024-08

3. HLA‐DQA1*01:03 and DQB1*06:01 are risk factors for severe COVID‐19 pneumonia;HLA;2024-07

4. Common human leucocyte antigensassociated with the development of subacute thyroiditis and COVID-19;Human Immunology;2024-07

5. DRB1 locus alleles of HLA class II are associated with modulation of the immune response in different serological profiles of HIV-1/Epstein-Barr virus coinfection in the Brazilian Amazon region;Frontiers in Medicine;2024-06-12